Forget expensive laboratory equipment costing thousands of dollars – University of Queensland researchers have cracked the code for a DNA analysis device you can literally print at home for the price of a decent dinner out. The Do-It-Yourself Nucleic Acid Fluorometer, cheekily dubbed DIYNAFLUOR, transforms genetic research from an exclusive club into a garage-friendly hobby.…
Archer Materials has achieved accuracy improvements in its blood potassium biosensor and successfully demonstrated lithium ion detection, according to a company announcement on Monday. The Adelaide-based semiconductor company said its Sydney engineering team has made measurable improvements to the sensor’s accuracy while building on early test results from February. The biosensor is designed to measure…
The National Reconstruction Fund Corporation has committed $150 million to Brandon Capital to accelerate Australian medical innovation commercialisation, according to an announcement on Thursday. The investment will be allocated to Brandon Capital’s BioCatalyst 6 fund and will support early and late-stage Australian medical science companies developing therapeutics, medical devices and vaccines. NRFC chief executive David…
Picture this: a building has collapsed after an earthquake, rescue crews are racing against time to find survivors buried in the rubble, and their secret weapon isn’t a robot or drone – it’s a beetle wearing a tiny backpack. University of Queensland researchers have turned science fiction into reality by creating what they cheerfully call…
Australian scientists have successfully transferred precision fermentation technology for creating dairy proteins from laboratory to industry, marking a breakthrough for alternative dairy production. The University of Queensland team, led by Professor Esteban Marcellin, has produced dairy proteins using Australia’s Food and Beverage Accelerator research bioreactors and transferred the technology to Sydney-based company All G for…
A Melbourne biotechnology company has become one of the first in Australasia to receive a licence to manufacture stem cells, potentially reducing Australia’s reliance on overseas bio-tech manufacturers. The Therapeutic Goods Administration granted Magellan Stem Cells the manufacturing licence for its Braeside facility in Melbourne’s southeast, the company announced this week. The decision places Magellan…
Sydney-based industrial biotechnology company MicroBioGen has struck a deal with French research and bioengineering group Lesaffre, initially focussing on baking, food and biochemicals. According to a statement from the pair on Thursday (Central European Time), the deal involves a “worldwide exclusive license and collaboration agreement” combining MicroBioGen’s expertise in yeast biotech with Lesaffre’s “bioengineering and…
AnteoTech announced on Thursday it had received a sales order worth $213,000 from the Serum Institute of India under their five-year purchase agreement. The Brisbane-based biotechnology company said its Life Sciences business unit was on track to achieve approximately $930,000 in sales for FY2025, representing an increase of about 130 per cent over FY2024. AnteoTech…
Bio-Gene Technology Limited announced on Monday it has successfully secured $2.1 million from sophisticated and professional investors, giving its insect-fighting arsenal a significant financial boost. The company isn’t just creating another bug spray for your kitchen cabinet. Bio-Gene is developing insecticides based on compounds found in nature that can outsmart resistant pests. Around 40 per…
Race Oncology opened patient enrolment at a second site for its Phase 1 clinical trial of RC220 in patients with advanced solid tumours, the company announced on Tuesday. The Central Coast Local Health District, comprising Gosford and Wyong Hospitals, has been activated following the earlier activation of the lead Australian site, Southside Cancer Centre in…